Publication Name	World Journal of Psychiatry
Manuscript ID	84995
Country	China

Received	2023-05-04 08:44
Peer-Review Started	2023-05-04 08:45
To Make the First Decision
Return for Revision	2023-05-15 00:36
Revised	2023-05-31 04:30
Second Decision	2023-06-21 02:58
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-06-21 08:29
Articles in Press	2023-06-21 08:29
Publication Fee Transferred
Edit the Manuscript by Language Editor	2023-06-27 21:08
Typeset the Manuscript	2023-07-10 03:35
Publish the Manuscript Online	2023-07-18 13:21

ISSN	2220-3206 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Psychiatry
Manuscript Type	Retrospective Study
Article Title	Repetitive transcranial magnetic stimulation combined with olanzapine and amisulpride for treatment-refractory schizophrenia
Manuscript Source	Unsolicited Manuscript
All Author List	Jin-Ling Liu, Zhi-Mei Tan and Shu-Jie Jiao
ORCID	Author(s) ORCID Number Shu-Jie Jiao http://orcid.org/0009-0007-2395-2425
Funding Agency and Grant Number
Corresponding Author	Shu-Jie Jiao, PhD, Doctor, Department of Neurology, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Erqi District, Zhengzhou 450000, Henan Province, China. jsj331253@126.com
Key Words	Repetitive transcranial magnetic stimulation; Olanzapine; Amisulpride; Treatment-refractory schizophrenia; Therapeutic effectiveness; Cognitive function
Core Tip	Patients with treatment-refractory schizophrenia (TRS) always have unsatisfactory treatment response and prognosis despite antipsychotic therapy, which poses significant challenges to clinical management. Therefore, it is necessary to continuously explore and validate effective treatments for TRS.
Publish Date	2023-07-18 13:21
Citation	Liu JL, Tan ZM, Jiao SJ. Repetitive transcranial magnetic stimulation combined with olanzapine and amisulpride for treatment-refractory schizophrenia. World J Psychiatry 2023; 13(7): 453-460
URL	https://www.wjgnet.com/2220-3206/full/v13/i7/453.htm
DOI	https://dx.doi.org/10.5498/wjp.v13.i7.453

Full Article (PDF)	WJP-13-453-with-cover.pdf
Full Article (Word)	WJP-13-453.docx
Manuscript File	84995-Review-Filipodia.docx
Answering Reviewers	84995-Answering reviewers.pdf
Audio Core Tip	84995-Audio core tip.mp3
Biostatistics Review Certificate	84995-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	84995-Conflict-of-interest statement.pdf
Copyright License Agreement	84995-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s)	84995-Informed consent statement.pdf
Institutional Review Board Approval Form or Document	84995-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate	84995-Language certificate.pdf
Peer-review Report	84995-Peer-review(s).pdf
Scientific Misconduct Check	84995-Bing-Wang JL-2.png
Scientific Misconduct Check	84995-CrossCheck.png
Scientific Editor Work List	84995-Scientific editor work list.pdf